Camilo Cortesi

Camilo Cortesi

Auto-generated profile, based on publicly available information

Camilo Cortesi

Department of Medicine, Division of Nephrology, University of California, San Francisco, California

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2022 in Kidney360
Verified
Journal Article
Closed access
PDF file
AMAdela Mattiazzi
Adela Mattiazzi
CCCamilo A. Cortesi
Camilo A. Cortesi
RPRhea J. Patil
Rhea J. Patil
KMKarla G. Carias Martinez
Karla G. Carias Martinez
MSMai Sedki
Mai Sedki
GGGiselle Guerra
Giselle Guerra
Key Points: Ultrasound-guided kidney transplant biopsy is considered safe, with similar complications rates regardless of the performing team. Besides well-known risk factors for complications, we found that sex and race are also predictors. The performance of kidney transplant biopsy remains an integral part of nephrology training. Background: Kidney transplant biopsies are the gold standard for evaluating allograft dysfunction. These biopsies are performed by nephrologists and radiologists under real-time ultrasound guidance. A few studies have examined the outcomes of ultrasound-guided kidney transplant biopsy in transplant recipients; however, none have compared these outcomes between both specialties. Methods: We retrospectively analyzed a cohort of 678 biopsies performed in a single center during a 44-month study period. Biopsies were stratified into two groups based upon the specialist performing the procedure: interventional radiology (IR; N=447) and transplant nephrology (TN; N=231). Results: There were 55 (8%) complications related to biopsies in the entire cohort: 37 (8.2%) in the IR group and 18 (7.7%) in the TN group, without statistical difference between the groups (P=0.94). Blood pressure control and prior use of anticoagulation were significant predictors of complicated biopsies (P=0.004 and 0.02, respectively). Being a woman and prior use of anticoagulation were significant predictors of transfusion of blood products (P=0.01 and 0.01, respectively). Being a woman and blood pressure control were significant predictors of overall perinephric hematoma (P=0.01 and 0.01, respectively), and Black race was a significant predictor of perinephric hematoma without worsening of renal function (P=0.005). The specialist team performing the procedure was not a statistically significant predictor of biopsy complications, transfusion of blood products, or perinephric hematoma with comparable sample yield. Conclusions: Percutaneous ultrasound-guided kidney transplant biopsy performed by transplant nephrologists have similar complication rates when compared with interventional radiologists in an academic center.

1 January 2017 in Clinical Medicine Insights: Therapeutics
Verified
Journal Article
Open access
CCCamilo Cortesi
Camilo Cortesi
MIMichel Ibrahim
Michel Ibrahim
FRFranco Cabeza Rivera
Franco Cabeza Rivera
GHGabriel A Hernandez
Gabriel A Hernandez
Cardiorenal syndrome is a group of disorders resulting from the pathological interaction between the heart and the kidneys. The most accepted classification of cardiorenal syndrome differentiates the types based on the temporal sequence of organ involvement. Although many mechanisms seem to be involved in the pathogenesis, cardiac hemodynamic changes are still considered one of the major parameters that affect the cross talk between these organs. As heart failure and chronic kidney disease reach endemic proportions, the necessity to understand the pathophysiology, hemodynamics, and effective therapy of cardiorenal syndrome becomes fundamental. The aim of this review is to identify and explain the hemodynamic changes behind the syndrome and evaluate potential noninvasive methods that can help develop a practical tool for managing the cardiorenal patient.

1 January 2018 in Saudi Journal of Kidney Diseases and Transplantation
Verified
Journal Article
Open access
PDF file
JDJuan C Duque
Juan C Duque
CCCamilo Cortesi
Camilo Cortesi
SMSedki Mai
Sedki Mai
LMLaisel Martinez
Laisel Martinez
ADAdriana Dejman
Adriana Dejman
MTMarwan Tabbara
Marwan Tabbara
Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.

1 April 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MSMai Sedki
Mai Sedki
CCCamilo Cortesi
Camilo Cortesi
RSRahul Sheth
Rahul Sheth
PMPaul Martin
Paul Martin
KBKalyan R. Bhamidimari
Kalyan R. Bhamidimari